JP2012507026A5 - - Google Patents

Download PDF

Info

Publication number
JP2012507026A5
JP2012507026A5 JP2011533750A JP2011533750A JP2012507026A5 JP 2012507026 A5 JP2012507026 A5 JP 2012507026A5 JP 2011533750 A JP2011533750 A JP 2011533750A JP 2011533750 A JP2011533750 A JP 2011533750A JP 2012507026 A5 JP2012507026 A5 JP 2012507026A5
Authority
JP
Japan
Prior art keywords
vegfb
thbs1
pgf
patient
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011533750A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012507026A (ja
JP5749171B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/064410 external-priority patent/WO2010049538A1/en
Publication of JP2012507026A publication Critical patent/JP2012507026A/ja
Publication of JP2012507026A5 publication Critical patent/JP2012507026A5/ja
Application granted granted Critical
Publication of JP5749171B2 publication Critical patent/JP5749171B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011533750A 2008-10-30 2009-10-30 バイオマーカー Expired - Fee Related JP5749171B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10964908P 2008-10-30 2008-10-30
US61/109,649 2008-10-30
PCT/EP2009/064410 WO2010049538A1 (en) 2008-10-30 2009-10-30 Biomarkers

Publications (3)

Publication Number Publication Date
JP2012507026A JP2012507026A (ja) 2012-03-22
JP2012507026A5 true JP2012507026A5 (https=) 2012-12-13
JP5749171B2 JP5749171B2 (ja) 2015-07-15

Family

ID=41528764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011533750A Expired - Fee Related JP5749171B2 (ja) 2008-10-30 2009-10-30 バイオマーカー

Country Status (9)

Country Link
US (2) US20110294683A1 (https=)
EP (1) EP2362942B1 (https=)
JP (1) JP5749171B2 (https=)
CN (1) CN102203606A (https=)
BR (1) BRPI0920069A8 (https=)
CA (1) CA2741117A1 (https=)
ES (1) ES2640900T3 (https=)
RU (1) RU2545757C2 (https=)
WO (1) WO2010049538A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG186953A1 (en) 2010-07-09 2013-02-28 Somalogic Inc Lung cancer biomarkers and uses thereof
CN103415624B (zh) 2010-08-13 2017-03-01 私募蛋白质体公司 胰腺癌生物标记及其用途
EP2592423A1 (en) 2011-11-08 2013-05-15 Zora Biosciences OY Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
EP2592422A1 (en) 2011-11-08 2013-05-15 Zora Biosciences OY Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
JP2014207883A (ja) * 2013-03-27 2014-11-06 国立大学法人岡山大学 がん幹細胞及びその用途
EP3511014A1 (en) * 2013-05-31 2019-07-17 CoBioRes NV Human plgf-2 for the prevention or treatment of heart failure resulting from chronic myocardial ischemia
EP3441768A3 (en) 2013-08-26 2019-03-20 Roche Diagnostics GmbH Marker for statin treatment stratification in heart failure
CN103487586B (zh) * 2013-09-04 2015-07-15 石家庄洹众生物科技有限公司 一种定量检测可溶性生长刺激表达蛋白2的试验装置
PL228091B1 (pl) * 2014-02-12 2018-02-28 Inst Biochemii I Biofizyki Polskiej Akademii Nauk Zestaw biomarkerów transkryptomicznych do zastosowania w stratyfikacji indywidualnego ryzyka rozwoju pozawałowej niewydolnosci serca, sposób diagnozowania ryzyka wystapienia u pacjenta pozawałowej niewydolnosci serca i zastosowanie biomarkerów do diagnostyki in vitro
US10041120B2 (en) 2014-05-28 2018-08-07 Scripps Health Predictive analysis for myocardial infarction
CN105243294B (zh) * 2015-09-18 2017-06-09 淮南师范学院 一种用于预测癌症病人预后相关的蛋白质对的方法
RU2634375C2 (ru) * 2016-04-18 2017-10-26 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт кардиологии" Способ предупреждения постинфарктного ремоделирования сердца в эксперименте
WO2018009723A1 (en) * 2016-07-06 2018-01-11 Guardant Health, Inc. Methods for fragmentome profiling of cell-free nucleic acids
DE102017116204B4 (de) * 2017-07-18 2024-06-27 Universität Rostock Verfahren zur Vorhersage der Antwort auf die kardiovaskuläre Regeneration
US11708600B2 (en) * 2017-10-05 2023-07-25 Decode Health, Inc. Long non-coding RNA gene expression signatures in disease diagnosis
CN114449944A (zh) * 2019-09-30 2022-05-06 豪夫迈·罗氏有限公司 疾病状态预测
JP7489059B2 (ja) * 2020-04-21 2024-05-23 国立大学法人横浜国立大学 画像生成装置、表示装置、画像生成方法、提示方法およびプログラム
US11854675B1 (en) 2022-10-11 2023-12-26 Flatiron Health, Inc. Machine learning extraction of clinical variable values for subjects from clinical record data
US11915807B1 (en) * 2022-10-11 2024-02-27 Flatiron Health, Inc. Machine learning extraction of clinical variable values for subjects from clinical record data

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2363488A1 (en) * 1999-03-03 2000-09-08 Ludwig Institute For Cancer Research Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities
CN1139811C (zh) * 1999-11-09 2004-02-25 赵永同 肿瘤早期检测评估试剂盒及其制备工艺
CN1260492A (zh) * 1999-11-09 2000-07-19 赵永同 肿瘤预后评估试剂盒及其制备工艺
DE60025526T2 (de) * 1999-11-16 2006-08-24 Genentech, Inc., South San Francisco Elisa für vegf
CN1441849A (zh) * 2000-05-17 2003-09-10 路德维格癌症研究所 检测肿瘤细胞的存在及筛选抗肿瘤剂的方法
CN1630538A (zh) * 2001-06-20 2005-06-22 路德维格癌症研究所 用vegf－b刺激血管生成
WO2003017038A2 (en) * 2001-08-13 2003-02-27 Genetics Development Corporation A molecular diagnostic and computerized decision support system for selecting the optimum treatment for human cancer
US20030096248A1 (en) * 2001-09-04 2003-05-22 Vitivity, Inc. Diagnosis and treatment of vascular disease
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
EP1962096B1 (de) * 2002-11-16 2012-07-18 Siemens Healthcare Diagnostics Products GmbH SCD40L, PAPP-A und plazentaler-Wachstumsfaktor (PIGF) als biochemische Markerkombination bei kardiovaskulären Erkrankungen
JP4949038B2 (ja) * 2003-12-01 2012-06-06 ダコ デンマーク アクティーゼルスカブ 免疫組織化学的検出のための方法および組成物
CN101426489A (zh) * 2004-04-16 2009-05-06 曹义海 抑制血管生成的成分和方法
US20070037232A1 (en) * 2005-03-31 2007-02-15 Barasch Jonathan M Detection of NGAL in chronic renal disease
TW200732347A (en) * 2005-10-06 2007-09-01 Trophogen Inc VEGF analogs and methods of use

Similar Documents

Publication Publication Date Title
JP2012507026A5 (https=)
RU2011121613A (ru) Биомаркеры
US20120219943A1 (en) Methods of prognosis and diagnosis in chronic heart failure
CN104144943B (zh) 评估肾结构改变和结果
JP2025029196A (ja) 心臓血管疾患及び事象のための診断及び予後方法
CA3052349C (en) Proadm as marker indicating an adverse event
Burrello et al. An extracellular vesicle epitope profile is associated with acute myocardial infarction
US20140045714A1 (en) Novel Biomarkers For Cardiovascular Injury
US20120295797A1 (en) Methods for diagnosis and prognosis of pulmonary hypertension
RU2764766C2 (ru) Гистоны и/или proadm в качестве маркеров, свидетельствующих об органной дисфункции
US20130210667A1 (en) Biomarkers for Predicting Kidney and Glomerular Pathologies
JP2017505436A5 (https=)
WO2018029214A1 (en) Histones and/or proadm as markers indicating an adverse event
WO2013006629A1 (en) Methods and compositions for assigning likelihood of acute kidney injury progression
JP6416778B2 (ja) 急性腎臓損傷
Argan et al. Associations between neutrophil gelatinase associated lipocalin, neutrophil-to-lymphocyte ratio, atrial fibrillation and renal dysfunction in chronic heart failure
WO2015164616A1 (en) Biomarkers for detection of tuberculosis
Baroni et al. A false positive case of high-sensitivity cardiac troponin in a patient with acute chest pain: Analytical study of the interference
CN104704365B (zh) 精神分裂症标记物组及其利用
WO2017136497A1 (en) Detection and treatment of il-17 and il-13 related conditions
US9952213B2 (en) Method for evaluating ischemic heart disease by assaying complement factor H or D
JP2024540836A5 (https=)
CN120539404B (zh) 一种辅助诊断系统性红斑狼疮的生物标志物及其应用
US8962257B2 (en) Methods for diagnosing heart failure and other cardiac diseases
CN121656576A (zh) 生物标志物在制备预测反复流产风险的产品中的应用